Back to DE D. E. Shaw & Co., Inc.
CLDX
Showing 8 of 25 quarters
Position history for DED. E. Shaw & Co., Inc.'s holdings in Celldex Therapeutics, Inc.
Yes. D. E. Shaw holds 17,826 shares of CLDX (Celldex Therapeutics), worth $663,305, as of its Q2 2026 13F filing. It reduced the position by 35,034 shares (-66.3%) from Q1 2026. D. E. Shaw has held CLDX since Q2 2021, across 21 quarterly 13F filings.
Current Value
$663,305
Current Shares
17,826
Total Value Change
-$27.4M
Total Shares Change
-807,291
Quarter-by-Quarter History
Other major holders of CLDX: FMR LLC, Wellington Management Group LLP